Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
2.
Colloids Surf B Biointerfaces ; 155: 538-543, 2017 Jul 01.
Article in English | MEDLINE | ID: mdl-28494432

ABSTRACT

Poly((2-dimethylamino)ethyl methacrylate) (PDMAEMA) nanogels were synthesized via surfactant-free free-radical polymerization technique in aqueous conditions utilizing N,N'-methylene-bis-acrylamide (MBA) as a crosslinking agent. The PDMAEMA nanogels were subsequently quaternized with acryloyl chloride in order to yield mucoadhesive materials which incorporate two mucoadhesive concepts; electrostatic interactions and covalent bond forming acrylate groups. The native PDMAEMA nanogels were found to exhibit good mucoadhesive properties on ex vivo bovine conjunctival tissues, which was found to increase proportionally with the degree of quaternization. With a view to determine the ocular drug delivery capabilities of the materials, both quaternized and native nanogels were loaded with pilocarpine hydrochloride via an absorption method, and their in vitro release profiles were analysed. The nanogels were found to exhibit a high loading capacity (>20% of total weight) and a sustained release over 6h.


Subject(s)
Drug Delivery Systems/methods , Eye/metabolism , Methacrylates/chemistry , Nylons/chemistry , Polyethylene Glycols/chemistry , Polyethyleneimine/chemistry , Acrylates/chemistry , Animals , Cattle , Conjunctiva/metabolism , Delayed-Action Preparations , Dynamic Light Scattering , Microscopy, Electron, Transmission , Miotics/administration & dosage , Miotics/chemistry , Miotics/pharmacokinetics , Nanogels , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Pilocarpine/administration & dosage , Pilocarpine/chemistry , Pilocarpine/pharmacokinetics , Tissue Adhesives/chemistry
3.
Biomaterials ; 33(7): 2372-87, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22182746

ABSTRACT

In this study, the aminated gelatin was grafted with carboxylic end-capped poly(N-isopropylacrylamide) (PN) via a carbodiimide-mediated coupling reaction to fabricate biodegradable in situ forming delivery systems for intracameral administration of antiglaucoma medications. The chemical structure of the graft copolymers (GN) was confirmed by Fourier transform infrared (FTIR) spectroscopy. When the feed molar ratio of NH(2)/COOH was 0.36, the grafting ratio, efficiency and degree of grafting, and weight ratio of PN to aminated gelatin was 25.6, 18.6%, 52.6%, and 1.9, respectively. As compared to PN, the GN samples possessed better thermal gelation ability and adherence, indicating remarkable phase transition properties. Under gelatinase degradation, the remaining weight of GN was significantly lower than those of PN at each time point from 8 h to 4 weeks. Cytocompatibility studies showed that the culture of anterior segment cells with both in situ forming gels does not affect proliferation and has little effect on inflammation. Higher encapsulation efficiency (~62%) and cumulative release (~95%) were achieved for GN vehicles, which was attributed to initial fast temperature triggered capture of pilocarpine and subsequent progressive degradation of gelatin network. In a rabbit glaucoma model, the performance of delivery carriers was evaluated by biomicroscopy, intraocular pressure (IOP), and pupil size change. Intracameral administration of pilocarpine using GN was found to be more effective than other methods such as instillation of eye drop and injection of free drug or PN containing drug in improving ocular bioavailability and extending the pharmacological responses (i.e., miosis and IOP lowering effect and preservation of corneal endothelial cell density).


Subject(s)
Acrylamides , Drug Carriers , Drug Delivery Systems/methods , Gelatin , Miotics/administration & dosage , Pilocarpine/administration & dosage , Polymers , Acrylamides/chemical synthesis , Acrylamides/chemistry , Acrylamides/metabolism , Acrylic Resins , Animals , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Biocompatible Materials/metabolism , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Carriers/metabolism , Gelatin/chemical synthesis , Gelatin/chemistry , Gelatin/metabolism , Glaucoma/drug therapy , Humans , Intraocular Pressure/drug effects , Materials Testing , Miotics/pharmacokinetics , Miotics/pharmacology , Miotics/therapeutic use , Molecular Structure , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/therapeutic use , Pilocarpine/pharmacokinetics , Pilocarpine/pharmacology , Pilocarpine/therapeutic use , Polymers/chemical synthesis , Polymers/chemistry , Polymers/metabolism , Rabbits , Spectroscopy, Fourier Transform Infrared
4.
Invest Ophthalmol Vis Sci ; 52(12): 9275-8, 2011 Nov 29.
Article in English | MEDLINE | ID: mdl-22064989

ABSTRACT

PURPOSE: To investigate the effect of cross-linking treatment on corneal permeability in a live animal model. METHODS: Rabbit eyes were selected at random to be left unoperated or to undergo epithelial debridement with or without treatment consisting of cross-linking (CXL) with riboflavin and ultraviolet-A. Nine eyes received a total dose of 3.6 J/cm² and after epithelial healing the corneas were placed in a two-chamber system for quantification of the diffusion of fluorescein compared with controls. Thirty eyes received a total dose of 5.4 J/cm² and, after epithelial healing, in vivo corneal permeability was quantified as the pupillary response over a 30-minute period to a dose of topical pilocarpine compared with controls. RESULTS: In the ex vivo assay, the mean permeability coefficient in the CXL group (2.42 × 10⁻7) was reduced when compared with the unoperated controls (3.73 × 10⁻7; P = 0.007) and to the eyes that received epithelial debridement alone (3.74 × 10⁻7; P = 0.01). In the in vivo permeability assay, the change in pupillary diameter at 30 minutes after pilocarpine administration was smaller in the CXL group (-1.9 mm), compared with the epithelial debridement group (-2.6 mm; P < 0.001) and with the unoperated controls (-2.7 mm; P = 0.003). CONCLUSIONS: Corneal cross-linking with ultraviolet-A and riboflavin results in a statistically significant reduction in corneal permeability. These findings suggest that dosing of topical medications may need to be increased in eyes with a history of CXL to achieve expected therapeutic effects, and they may have implications for the long-term health of the cornea.


Subject(s)
Cornea/metabolism , Cross-Linking Reagents/pharmacology , Photosensitizing Agents/pharmacology , Riboflavin/pharmacology , Ultraviolet Rays , Animals , Collagen/metabolism , Corneal Stroma/metabolism , Debridement , Female , Fluorescein/metabolism , Miotics/pharmacokinetics , Permeability/drug effects , Pilocarpine/pharmacokinetics , Pupil/drug effects , Rabbits , Spectrometry, Fluorescence
5.
Yao Xue Xue Bao ; 46(8): 990-6, 2011 Aug.
Article in Chinese | MEDLINE | ID: mdl-22007526

ABSTRACT

The study is to design chitosan-coated pilocarpine nitrate submicro emulsion (CS-PN/SE) for the development of a novel mucoadhesive submicro emulsion, aiming to prolong the precorneal retention time and improve the ocular absorption. CS-PN/SE was fabricated in two steps: firstly, pilocarpine nitrate submicro emulsion (PN/SE) was prepared by high-speed shear with medium chain triglycerides (MCT) as oil phase and Tween 80 as the main emulsifier, and then incubated with chitosan (CS) acetic solution. The preparation process was optimized by central composite design-response surface methodology. Besides the particle size, zeta potential, entrapment efficiency and micromorphology were investigated, CS-PN/SE's precorneal residence properties and miotic effect were especially studied using New Zealand rabbits as the animal model. When CS-PN/SE was administered topically to rabbit eyes, the ocular clearance and the mean resident time (MRT) of pilocarpine nitrate were found to be dramatically improved (P < 0.05) compared with PN/SE and pilocarpine nitrate solution (PNs), since the K(CS-PN/SE) was declined to 0.006 4 +/- 0.000 3 min(-1) while MRT was prolonged up to 155.4 min. Pharmacodynamics results showed that the maximum miosis of CS-PN/SE was as high as 46.3%, while the miotic response lasted 480 min which is 255 min and 105 min longer than that of PNs and PN/SE, respectively. A larger area under the miotic percentage vs time curve (AUC) of CS-PN/SE was exhibited which is 1.6 folds and 1.2 folds as much as that of PNs and PN/SE, respectively (P < 0.05). Therefore, CS-PN/SE could enhance the duration of action and ocular bioavailability by improving the precorneal residence and ocular absorption significantly.


Subject(s)
Chitosan/chemistry , Miotics/administration & dosage , Pilocarpine/administration & dosage , Absorption , Animals , Area Under Curve , Biological Availability , Cornea/metabolism , Emulsions , Microscopy, Electron, Transmission , Miotics/chemistry , Miotics/pharmacokinetics , Ophthalmic Solutions , Particle Size , Pilocarpine/chemistry , Pilocarpine/pharmacokinetics , Rabbits , Random Allocation , Solubility , Tears/metabolism
6.
Int J Pharm ; 411(1-2): 78-85, 2011 Jun 15.
Article in English | MEDLINE | ID: mdl-21453763

ABSTRACT

In situ gelling systems are viscous polymer-based solutions that exhibit a sol-to-gel phase transition upon change in a physicochemical parameter such as ionic strength, temperature or pH, therefore prolonging the formulations' residence time on the ocular surface. Ion-activated in situ gelling systems, that are able to crosslink with the cations in the tear fluid, have previously been evaluated in terms of their rheological, textural and in vitro release characteristics. The present study describes the ocular irritancy, precorneal retention time and in vivo release characteristics of the same formulations. It was shown that all tested polymer systems were non-irritant. Precorneal retention studies revealed a biphasic rapid release for the solution with less than 40% radioactivity left on the ocular surface after 15 min, while formulations based on gellan gum, xanthan gum and carrageenan seemed to drain at an almost constant rate with more than 80% radioactivity remaining. This was in agreement with the in vivo miotic studies, which demonstrated that the area under the curve and the miotic response at 120 min after administration for gellan gum, xanthan gum and carrageenan formulations of pilocarpine were increased by 2.5-fold compared to an aqueous solution, which demonstrates their potential use in ophthalmic formulations.


Subject(s)
Cornea/chemistry , Drug Delivery Systems , Gels/pharmacokinetics , Miotics/pharmacokinetics , Ophthalmic Solutions/pharmacokinetics , Pilocarpine/chemistry , Animals , Anions , Carrageenan/administration & dosage , Carrageenan/chemistry , Carrageenan/pharmacokinetics , Chemical Phenomena , Cornea/metabolism , Excipients/administration & dosage , Excipients/chemistry , Excipients/pharmacokinetics , Eye/chemistry , Gels/administration & dosage , Gels/chemistry , Humans , Male , Miotics/administration & dosage , Miotics/chemistry , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/chemistry , Pilocarpine/administration & dosage , Pilocarpine/pharmacokinetics , Polysaccharides, Bacterial/analysis , Polysaccharides, Bacterial/chemistry , Polysaccharides, Bacterial/metabolism , Rabbits , Viscosity
7.
Invest Ophthalmol Vis Sci ; 52(5): 2627-33, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21245405

ABSTRACT

PURPOSE: To test the hypothesis that mucoadhesive microparticles formulated in a rapidly dissolving tablet can achieve sustained drug delivery to the eye. METHODS: Mucoadhesive microparticles, smaller than 5 µm were fabricated with poly(lactic-co-glycolic acid) and poly(ethylene glycol) as a core material and mucoadhesion promoter, respectively, and encapsulated pilocarpine as a model drug. These microparticles were embedded in a poly(vinyl alcohol) matrix to form a dry tablet designed to reduce rapid clearance of the microparticles on initial application to the eye. RESULTS: This in vitro drug release study exhibited that for all formulations, approximately 90% of pilocarpine was released during the first 10 minutes, and the remaining 10% was released slowly for 3 hours. In vivo mucoadhesion test on the rabbit eye indicated that mucoadhesive microparticles adhered significantly better to the preocular surface than other formulations. To assess the pharmacodynamics, the most prolonged pilocarpine-induced pupil constriction was observed in rabbit eyes in vivo using a tablet with mucoadhesive microparticles; it lasted up to 330 minutes. CONCLUSIONS: The authors conclude that mucoadhesive microparticles formulated into a dry dosage form is a promising system for sustained drug delivery to the eye.


Subject(s)
Drug Carriers , Drug Delivery Systems/instrumentation , Miotics/administration & dosage , Pilocarpine/administration & dosage , Polyethylene Glycols , Polyglactin 910 , Pupil/drug effects , Tablets , Adhesiveness , Animals , Biological Availability , Drug Delivery Systems/methods , Female , Iris/metabolism , Microspheres , Miotics/pharmacokinetics , Pilocarpine/pharmacokinetics , Rabbits
8.
J Biomater Sci Polym Ed ; 18(2): 205-21, 2007.
Article in English | MEDLINE | ID: mdl-17323854

ABSTRACT

Chitosan-poly(acrylic acid) (CS-PAA) nanoparticles, to be used as ophthalmic drug carrier, were successfully prepared using template polymerization of acrylic acid (AA) in a chitosan solution. When the polymerization was done at 70 degrees C for 45 min with a CS/AA weight ratio of 1:1, the surface structure of the prepared nanoparticles was most stable with the smallest mean diameter (92.0 +/- 7.5 nm) and a stable zeta potential (25.5 +/- 2.6 mV) in a buffer solution (pH 4.5). The size of the nanoparticles dramatically increased with the pH value of the medium. Both in vitro and in vivo studies revealed that the prepared nanoparticle suspension was better at sustaining the release of pilocarpine than either simulated tear fluid or commercial eye drops.


Subject(s)
Acrylic Resins , Chitosan , Miotics/administration & dosage , Pilocarpine/administration & dosage , Acrylic Resins/chemistry , Animals , Biocompatible Materials/chemistry , Chitosan/chemistry , Drug Carriers , Female , Hydrogen-Ion Concentration , In Vitro Techniques , Male , Materials Testing , Miotics/pharmacokinetics , Molecular Weight , Nanoparticles , Ophthalmic Solutions , Particle Size , Pilocarpine/pharmacokinetics , Rabbits , Spectroscopy, Fourier Transform Infrared , Suspensions
10.
Int J Pharm ; 272(1-2): 57-64, 2004 Mar 19.
Article in English | MEDLINE | ID: mdl-15019069

ABSTRACT

Solutions of surface active triblock copolymer Pluronic F127 in the vicinity of the critical micellar concentration (cmc) were prepared with or without pilocarpine (either as the hydrochloride salt or the free base) in water and phosphate buffer. The characteristics parameters of the surface activity (cmc, Gamma and a) were determined for F127 solutions. Additionally, it was found that the pilocarpine solutions without F127 in water exhibits a certain surface activity. The solutions containing F127 (2 wt.%) well above the cmc and pilocarpine (2 wt.% for the salt, or equimolar 1.7 wt.% for the base) were further tested in vivo (miotic response) on rabbit eye. Though the entrapment efficiency of the drug in the micelles was rather low (maximal 1.9%) the pharmacokinetic parameters (duration of miotic response and the area under miotic curve) were improved when compared to the standard pilocarpine solutions. The best results were obtained for the micellar pilocarpine base solution which exhibits significant prolongation of miotic activity and an increase of AUC for 64%.


Subject(s)
Miotics/pharmacokinetics , Pilocarpine/pharmacokinetics , Poloxamer/chemistry , Surface-Active Agents/chemistry , Administration, Topical , Animals , Chemical Phenomena , Chemistry, Physical , Drug Carriers , Eye/metabolism , Female , Micelles , Miotics/administration & dosage , Miotics/chemistry , Ophthalmic Solutions , Particle Size , Pilocarpine/administration & dosage , Pilocarpine/chemistry , Rabbits , Surface Tension , Time Factors
11.
Br J Ophthalmol ; 88(4): 560-5, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15031177

ABSTRACT

AIMS: For the study of transcorneal in vitro permeation of ophthalmic drugs, excised animal cornea or corneal epithelial cell culture are frequently used as a replacement for the human cornea. The main purposes of this study were to reconstruct a complete human organotypic cornea equivalent, consisting of all three different cell types (epithelial, stromal, and endothelial); to test the barrier function of this bio-engineered human cornea using three different model drugs (pilocarpine hydrochloride (PHCl), befunolol hydrochloride (BHCl), and hydrocortisone (HC)); and to determine its usefulness as an in vitro model for prediction of ocular drug absorption into the human eye. METHODS: A multilayer tissue construct was created step by step in Transwell cell culture insert using SV-40 immortalised human endothelial and epithelial cells and native stromal cells (fibroblasts). Morphology was characterised by light microscopy using routine H&E staining. Scanning electron microscopy was used to evaluate ultrastructural features. Ocular permeation of drugs across the human cornea construct was tested using modified Franz cells and compared with data obtained from excised porcine cornea and previously described porcine cornea constructs. RESULTS: and conclusion: The cornea construct exhibited typical corneal structures such as a monolayer of hexagonally shaped endothelial cells and a multilayered epithelium consisting of seven to nine cell layers with flat superficial cells. The formation of microplicae and microvilli was also confirmed. The human cornea construct showed similar permeation behaviour for all substances compared with excised porcine cornea. However, permeability (permeation coefficients K(p)) of the human cornea equivalent (PHCl 13.4*10(-6) (SD 3.01*10(-6)); BHCl 9.88*10(-6) (SD 1.79*10(-6)); HC 5.41*10(-6) (SD 0.40*10(-6)) cm/s) was about 1.6-1.8 fold higher than excised porcine cornea. Compared with data from the porcine cornea construct the cultivated human equivalent showed a decreased permeability. The reconstructed human cornea could be appropriate to predict drug absorption into the human eye.


Subject(s)
Cornea/metabolism , Ophthalmic Solutions/pharmacokinetics , Tissue Engineering , Adrenergic beta-Antagonists/pharmacokinetics , Cornea/drug effects , Humans , Hydrocortisone/pharmacokinetics , Microscopy, Electron, Scanning , Miotics/pharmacokinetics , Permeability , Pilocarpine/pharmacokinetics , Propanolamines/pharmacokinetics
12.
Am J Ophthalmol ; 133(3): 333-6, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11860969

ABSTRACT

PURPOSE: To determine the amount of pupillary constriction to four different concentrations of pilocarpine in normal human subjects and to determine if pupillary constriction correlates with bioavailability of the instilled concentrations. The amount of pupillary constriction to dilute pilocarpine is utilized as a diagnostic test for Adie tonic pupil as distinguished from a normal pupil response. DESIGN: Twenty healthy volunteers had automated binocular infrared pupillography in the dark after instillation of four different concentrations of dilute pilocarpine. Ocular penetration of eye drops was also assessed using 2% fluorescein sodium as a tracer. METHODS: Prospective institutional double-masked study of both eyes of twenty healthy volunteers, ten with brown irides, ten with blue irides, between the ages of 20-40 years. RESULTS: A pilocarpine dose-dependent curve showed decreased pupil size within 15 minutes, peaking at 30-60 minutes. No difference was noted between right and left eyes, iris color, or corneal permeability. CONCLUSIONS: Normal pupils constrict to dilute concentrations of pilocarpine (0.25% or 0.125%), but constrict insignificantly to concentrations of 0.0313% or 0.0625%. Pupil constriction with 0.0625% pilocarpine should distinguish an Adie pupil from normal. This confirms the utility of this simple office diagnostic procedure.


Subject(s)
Miotics/administration & dosage , Pilocarpine/administration & dosage , Pupil/drug effects , Tonic Pupil/diagnosis , Adult , Biological Availability , Cornea/metabolism , Double-Blind Method , Eye Color , Female , Fluorophotometry , Humans , Male , Miotics/pharmacokinetics , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/pharmacokinetics , Pilocarpine/pharmacokinetics , Prospective Studies , Tears/metabolism
14.
Int J Pharm ; 229(1-2): 29-36, 2001 Oct 23.
Article in English | MEDLINE | ID: mdl-11604255

ABSTRACT

Thermoreversible gels formed in situ by aqueous solutions of an enzyme-degraded xyloglucan polysaccharide were evaluated as sustained release vehicles for the ocular delivery of pilocarpine hydrochloride. In vitro release of pilocarpine from gels formed by warming xyloglucan sols (1.0, 1.5 and 2.0% w/w) to 34 degrees C followed root-time kinetics over a period of 6 h. The miotic responses in rabbit following administration of xyloglucan sols were compared with those from in situ gelling Pluronic F127 sols and from an aqueous buffer solution containing the same drug concentration. Sustained release of pilocarpine was observed with all gels, the duration of miotic response increasing with increase of xyloglucan concentration. The degree of enhancement of miotic response following sustained release of pilocarpine from the 1.5% w/w xyloglucan gel was similar to that from a 25% w/w Pluronic F127 gel.


Subject(s)
Glucans , Miotics/administration & dosage , Pilocarpine/administration & dosage , Polysaccharides/chemistry , Xylans , Animals , Delayed-Action Preparations , Excipients , Gels , Miotics/chemistry , Miotics/pharmacokinetics , Ophthalmic Solutions , Pilocarpine/chemistry , Pilocarpine/pharmacokinetics , Poloxamer , Pupil/drug effects , Rabbits , Viscosity
15.
Biomaterials ; 22(13): 1763-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11396879

ABSTRACT

This work investigates pilocarpine trapped in a matrix diffusion-controlled drug delivery system using hydrophilic inserts of Poly(2-hydroxyethyl methacrylate) (pHEMA) to ensure an increased bioavailability of pilocarpine and prolong the length of time in which the medication remains in the eyes of the test subjects. The physical and chemical properties of pilocarpine were investigated to elucidate the mechanism of drug-polymer interaction and the effect on drug release behavior of controlled release polymeric devices. In vitro release studies indicated that pilocarpine continued to be released from the inserts for a 24 h period. The results of intraocular pressure tests performed on albino rabbits were consistent with the observed in vitro behavior. The pressure decrease was significant for a period longer than 48 h. It confirms that the inserts, as sustainable releasing devices, are promising carriers for ophthalmic drug delivery systems.


Subject(s)
Miotics/administration & dosage , Muscarinic Agonists/administration & dosage , Pilocarpine/administration & dosage , Polyhydroxyethyl Methacrylate , Animals , Biological Availability , Drug Carriers , Miotics/pharmacokinetics , Muscarinic Agonists/pharmacokinetics , Pilocarpine/pharmacokinetics , Rabbits , Spectroscopy, Fourier Transform Infrared , X-Ray Diffraction
16.
J Microencapsul ; 18(2): 173-81, 2001.
Article in English | MEDLINE | ID: mdl-11253934

ABSTRACT

Submicron emulsions containing 2.0% w/v pilocarpine as pilocarpine HCl, soybean oil (10% w/v) and egg lecithin (1.2% w/v) were formulated. Emulsions at pH 5.0, 6.5 and 8.5 were applied to the rabbit's eye, and the reduction in pupil diameter was measured for 6 h. The miotic effect was compared with that obtained with aqueous solutions at the same pH. A prolonged miotic effect was observed when the submicron emulsion was used as a vehicle. After application of emulsions at pH 5.0, 6.5 or 8.5, the time when 20% reduction of pupil diameter was still observed was 3.9 +/- 1.1 h, 4.3 +/- 1.3 h and 5.3 +/- 0.8 h, respectively, while, after application of a solution, this parameter was shorter by 30-40%. AUC(0-6h) values were larger after application of the submicron emulsions in comparison to aqueous solutions; however, statistically significant differences were only observed for emulsions at pH 6.5. Although the bioavailability of the drug is pH dependent, emulsions at higher pH cannot be considered for clinical use because of pilocarpine degradation which occurs with a similar rate as in aqueous solutions. Introduction of pilocarpine into the oily phase in the form of pilocarpine base or its oleate did not improve either the physicochemical or the pharmacological properties of the formulations. Irrespective of the pH and chemical form of pilocarpine used for emulsion preparation, practically all drug was found in the aqueous phase of the emulsion; thus, partitioning to the oily phase was negligible.


Subject(s)
Miotics/chemistry , Miotics/pharmacology , Muscarinic Agonists/chemistry , Muscarinic Agonists/pharmacology , Pilocarpine/chemistry , Pilocarpine/pharmacology , Animals , Biological Availability , Chemistry, Pharmaceutical , Drug Stability , Emulsions , Hydrogen-Ion Concentration , Kinetics , Miotics/pharmacokinetics , Muscarinic Agonists/pharmacokinetics , Particle Size , Pilocarpine/pharmacokinetics , Rabbits
17.
Eur J Pharm Biopharm ; 51(2): 119-25, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11226818

ABSTRACT

The aim of the present contribution was to develop a functional three-dimensional tissue construct to study ocular permeation of pilocarpine hydrochloride from different formulations. The in vitro model was compared to excised bovine cornea. Modified Franz cells were used to study the transcorneal permeability. Analysis was performed by reversed-phase high-performance liquid chromatography. Comparisons of the permeation rates through excised bovine cornea and the in vitro model show the same rank order for the different formulations. The permeation coefficient, K(P), obtained with the cornea construct, is about 2-4-fold higher than that from excised bovine cornea. It is possible to reconstruct bovine cornea as an organotypic culture and also to use this construct as a substitute for excised bovine cornea in drug permeation studies in vitro.


Subject(s)
Cornea/metabolism , Miotics/pharmacokinetics , Pilocarpine/pharmacokinetics , Animals , Cattle , Cell Size , Cells, Cultured , Chromatography, High Pressure Liquid , Cornea/cytology , Endothelium, Corneal/cytology , Humans , Miotics/chemistry , Ophthalmic Solutions/chemistry , Organ Culture Techniques , Permeability , Pilocarpine/chemistry , Solutions
18.
Br J Pharmacol ; 132(5): 1145-53, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11226146

ABSTRACT

Specific mechanisms, providing reuptake of cathecholamine and amino acid neurotransmitters (e.g. serotonin and glutamate) into cells of the central nervous system are well known, whereas neuronal uptake of neuropeptide transmitters have not previously been reported. In the present study we present evidence for uptake of the 37 amino acid neuropeptide, calcitonin gene-related peptide (CGRP) into perivascular terminals of capsaicin sensitive nerve fibres, innervating the guinea-pig basilar artery. Release of CGRP from perivascular nerve terminals was obtained by capsaicin-induced vanilloid receptor-stimulation and detected as CGRP receptor-mediated dilation of isolated segments of the guinea-pig basilar artery. Following three repeated capsaicin challenges, CGRP-depleted segments were incubated with CGRP. This caused significant reappearance of capsaicin-induced vasodilatory responses. These responses were dependent on duration and concentration of the preceding CGRP incubation and were inhibited by the CGRP receptor antagonist, CGRP(8 - 37). The CGRP-re-depletion was significantly reduced when CGRP(8 - 37) was present during the preceding CGRP incubation. Thus, presynaptic CGRP receptors are likely to be involved in neuronal CGRP uptake. Incubating the artery segments with (125)I-CGRP allowed subsequent detection of capsaicin-induced (125)I-release. Immunohistochemical experiments showed that only terminal CGRP is subject to capsaicin-induced depletion in vitro, whereas CGRP-immunoreactivity endures in the nerve fibres.


Subject(s)
Basilar Artery/metabolism , Calcitonin Gene-Related Peptide/pharmacokinetics , Presynaptic Terminals/metabolism , Vasodilation/physiology , Animals , Basilar Artery/drug effects , Calcitonin Gene-Related Peptide/drug effects , Calcitonin Gene-Related Peptide/metabolism , Capsaicin/pharmacology , Guinea Pigs , Miotics/pharmacokinetics , Peptide Fragments/pharmacokinetics , Presynaptic Terminals/drug effects , Vasodilation/drug effects
19.
Int J Pharm ; 202(1-2): 161-4, 2000 Jul 20.
Article in English | MEDLINE | ID: mdl-10915939

ABSTRACT

Submicron emulsions containing pilocarpine as ion-pair with mono-dodecylphosphoric acid were prepared. Physical stability of these preparations was confirmed during 4 months of storage at 4 degrees C. Approximately 50% of the drug was found in the aqueous phase of emulsion separated using an ultrafiltration technique, while the rest was present in the oily phase and interphase. The miotic effect observed in rabbits after application of the ion-pair in aqueous solution or in submicron emulsion was the same; indicating that the drug distribution into the oily phase of the colloidal vehicle does not improve ocular bioavailability.


Subject(s)
Iris/metabolism , Miotics/pharmacokinetics , Pilocarpine/pharmacokinetics , Pupil/drug effects , Soybean Oil/administration & dosage , Animals , Drug Carriers , Emulsions/administration & dosage , Emulsions/chemistry , Emulsions/pharmacokinetics , Liposomes , Miotics/administration & dosage , Miotics/chemistry , Pilocarpine/administration & dosage , Pilocarpine/chemistry , Rabbits , Soybean Oil/chemistry , Soybean Oil/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...